Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac Dosing for Acute Vaso-Occlusive Crisis in Pediatric SCD
NCT06579703Phase 4Not yet recruiting
- Sponsor
- Children's Blood and Cancer Center at Dell Children's Medical Center
- Start
- Sep 2024
- Primary completion
- Jul 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ketorolac in vaso-occlusive crisis (VOC), sponsored by Children's Blood and Cancer Center at Dell Children's Medical Center. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
ketorolac
03
Conditions
vaso-occlusive crisis (VOC)
Beyond the preview
Go deeper on NCT06579703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06579703.